Evidence map›Paper›PMID 35574959›Full record

SynthesisJournal of the American Heart Association2022

Clinical Prediction Models for Heart Failure Hospitalization in Type 2 Diabetes: A Systematic Review and Meta-Analysis.

Amir Razaghizad, Emily Oulousian, Varinder Kaur Randhawa, João Pedro Ferreira, James M Brophy, Stephen J Greene, Julian Guida, G Michael Felker, Marat Fudim, Michael Tsoukas and 5 more

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Journal of the American Heart Association, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Amir RazaghizadCentre for Outcomes Research and Evaluation Research Institute of the McGill University Health Centre Montreal QC Canada.ORCID 0000-0001-8397-7949
Emily OulousianDREAM-CV Laboratory McGill University Health CentreMcGill University Montreal Quebec Canada.
Varinder Kaur RandhawaDepartment of Cardiovascular Medicine Kaufman Center for Heart Failure and Recovery Heart, Vascular and Thoracic Institute Cleveland Clinic Cleveland OH.ORCID 0000-0001-9968-9618
João Pedro FerreiraUniversity of LorraineInserm, Centre d'Investigations Cliniques, - Plurithématique 14-33, Inserm U1116CHRUF-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists) Nancy France.ORCID 0000-0002-2304-6138
James M BrophyCentre for Outcomes Research and Evaluation Research Institute of the McGill University Health Centre Montreal QC Canada.ORCID 0000-0001-8049-6875
Stephen J GreeneDivision of Cardiology Duke University School of Medicine Durham NC.ORCID 0000-0001-6912-7374
Julian GuidaDREAM-CV Laboratory McGill University Health CentreMcGill University Montreal Quebec Canada.
G Michael FelkerDivision of Cardiology Duke University School of Medicine Durham NC.ORCID 0000-0002-5931-1239
Marat FudimDivision of Cardiology Duke University School of Medicine Durham NC.ORCID 0000-0002-8671-7007
Michael TsoukasDivision of Endocrinology Department of Medicine McGill University Montreal QC Canada.
Tricia M PetersDivision of Endocrinology Department of Medicine McGill University Montreal QC Canada.
Thomas A MavrakanasDivision of Nephrology Department of Medicine McGill University Health Centre and Research Institute Montreal Canada.ORCID 0000-0002-3368-247X
Nadia GiannettiDivision of Cardiology McGill University Health CentreMcGill University Montreal Quebec Canada.ORCID 0000-0001-7173-8051
Justin EzekowitzDivision of Cardiology University of Alberta Edmonton Alberta Canada.ORCID 0000-0002-2724-4086
Abhinav SharmaCentre for Outcomes Research and Evaluation Research Institute of the McGill University Health Centre Montreal QC Canada.ORCID 0000-0002-2346-8330

Funding

Congestion Phenotypes and Splanchnic Nerve Modulation in Chronic Heart FailureK23HL151744 · NHLBI · DUKE UNIVERSITY · PI FUDIM, MARAT · 2021 to 2022
$376k
NHLBI NIH HHS K23 HL151744
6 · The paper itself

Abstract

Background Clinical prediction models have been developed for hospitalization for heart failure in type 2 diabetes. However, a systematic evaluation of these models' performance, applicability, and clinical impact is absent. Methods and Results We searched Embase, MEDLINE, Web of Science, Google Scholar, and Tufts' clinical prediction registry through February 2021. Studies needed to report the development, validation, clinical impact, or update of a prediction model for hospitalization for heart failure in type 2 diabetes with measures of model performance and sufficient information for clinical use. Model assessment was done with the Prediction Model Risk of Bias Assessment Tool, and meta-analyses of model discrimination were performed. We included 15 model development and 3 external validation studies with data from 999 167 people with type 2 diabetes. Of the 15 models, 6 had undergone external validation and only 1 had low concern for risk of bias and applicability (Risk Equations for Complications of Type 2 Diabetes). Seven models were presented in a clinically useful manner (eg, risk score, online calculator) and 2 models were classified as the most suitable for clinical use based on study design, external validity, and point-of-care usability. These were Risk Equations for Complications of Type 2 Diabetes (meta-analyzed c-statistic, 0.76) and the Thrombolysis in Myocardial Infarction Risk Score for Heart Failure in Diabetes (meta-analyzed c-statistic, 0.78), which was the simplest model with only 5 variables. No studies reported clinical impact. Conclusions Most prediction models for hospitalization for heart failure in patients with type 2 diabetes have potential concerns with risk of bias or applicability, and uncertain external validity and clinical impact. Future research is needed to address these knowledge gaps.

Indexed as

Diabetes Mellitus, Type 2Heart FailureHospitalizationHumansModels, StatisticalPrognosisclinical prediction modelsdiabetesheart failuremeta‐analysisprognosticationrisk evaluationsystematic review

Identifiers

PMID35574959
PMCPMC9238543

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.